Stonepine Capital Management, LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001440771

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallHealth TiltHigh Turnover how tags are computed

Q1 2025 · 66 positions · Total reported value $102.76M · Top-10 concentration 58.1% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 72.7% · 16 new · 27 cut · 29 exited

Active Share (vs S&P 500): 99.9% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -2.9% · vs SPY -5.0% · Prev Value $151.28M — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -4.9% · vs SPY -7.1% · Latest Value $130.24M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q1 2025 13F filing, Stonepine Capital Management, LLC disclosed 66 equity positions with a combined reported value of $102.76M. The filing implies a moderately concentrated portfolio: its ten largest positions account for 58.1% of reported value. HoldingsHub classifies the profile as Small / Health Tilt / High Turnover.

The largest disclosed positions as of Q1 2025 were ANIP ($13.65M), EOLS ($13.65M), OPTN ($7.23M). By sector, the heaviest allocations are Health Care 80.9%, Other 19.1%. Versus the prior quarter, allocation shifted toward Other (+1.7pp) and away from Health Care (-1.7pp).

Versus the prior quarter, Stonepine Capital Management, LLC opened 16 new positions, trimmed 27 and fully exited 29, a turnover rate of 72.7% of positions. The portfolio's overlap with the prior quarter was 58% of names.

The largest new positions opened in Q1 2025 were EDSA ($1.68M), KROS ($1.02M), GERN ($795.00K).

Of the 29 positions fully exited versus the prior quarter, the largest were IRWD ($2.87M), JAZZ ($1.23M), TSVT ($882.00K).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q1 2025)

  • EDSA EDESA BIOTECH INC · $1.68M
  • KROS KEROS THERAPEUTICS INC · $1.02M
  • GERN GERON CORP · $795.00K
  • THRD THIRD HARMONIC BIO INC · $738.36K
  • GRCE GRACE THERAPEUTICS INC · $665.68K
  • COLL COLLEGIUM PHARMACEUTICAL INC · $615.12K
  • YMAB Y-MABS THERAPEUTICS INC · $581.04K
  • NBP NOVABRIDGE BIOSCIENCES · $398.48K

Fully Exited (vs previous quarter)

  • IRWD IRONWOOD PHARMACEUTICALS INC · prev qtr: $2.87M
  • JAZZ JAZZ PHARMACEUTICALS PLC · prev qtr: $1.23M
  • TSVT 2SEVENTY BIO INC · prev qtr: $882.00K
  • ANTX AN2 THERAPEUTICS INC · prev qtr: $271.49K · history
  • ELEV ELEVATION ONCOLOGY INC · prev qtr: $112.52K
  • ABVX ABIVAX SA · prev qtr: $109.80K
  • ALLR ALLARITY THERAPEUTICS INC · prev qtr: $78.73K
  • RVNC REVANCE THERAPEUTICS INC · prev qtr: $70.72K

Insider Transactions (Form 4)

Latest Stonepine Capital Management, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Stonepine Capital Management, LLC is an SEC-registered 13F filer based in Bend, OR, United States. As of Q2 2026 it reported 83 US equity positions with a combined value of $151.28M. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: BEND, OR, United States
  • SEC registration: 801-136874 (status: Approved), registered 2026-07-22
  • Regulatory AUM (Form ADV): $181.00M as of 2026-06-26
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 1 private funds, of which 1 hedge funds
  • Website: stonepinecap.com

Portfolio Structure

  • 83 positions · $151.28M reported value (Q2 2026)
  • Top 10 holdings = 44.6% of reported value
  • Largest position: VSTM (VERASTEM INC) at 8.5%
  • Average position size: $1.82M

Sector Tilt

  • Health Care 99.8%
  • Industrials 0.2%
  • Materials 0.0%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 23 new, 28 added, 24 reduced, 12 exited
  • 8 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 80.9%
Other 19.1%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 1.13M $13.65M 13.28%
13.28%
Reduce
2 48.00K $13.65M 13.28%
13.28%
Add
3 788.65K $7.23M 7.04%
7.04%
Add
4 650.00K $4.87M 4.74%
4.74%
Add
5 613.00K $3.70M 3.60%
3.60%
Reduce
6 333.40K $3.69M 3.59%
3.59%
Add
7 285.78K $3.33M 3.24%
3.24%
Add
8 590.74K $3.26M 3.17%
3.17%
Add
9 206.64K $3.26M 3.17%
3.17%
Reduce
10 200.00K $3.04M 2.96%
2.96%
Add
11 74.50K $3.04M 2.96%
2.96%
Reduce
12 304.00K $2.90M 2.82%
2.82%
Hold
13 527.84K $2.77M 2.69%
2.69%
Reduce
14 348.82K $2.77M 2.69%
2.69%
Add
15 129.81K $2.59M 2.52%
2.52%
Add
16 2.06M $2.51M 2.44%
2.44%
Reduce
17 93.97K $2.36M 2.30%
2.30%
Reduce
18 914.97K $2.00M 1.95%
1.95%
Reduce
19 796.10K $1.75M 1.70%
1.70%
Add
20 687.50K $1.68M 1.63%
1.63%
New
21 276.71K $1.33M 1.29%
1.29%
Add
22 100.00K $1.02M 0.99%
0.99%
New
23 144.63K $937.19K 0.91%
0.91%
Reduce
24 347.69K $914.42K 0.89%
0.89%
Reduce
25 518.33K $844.88K 0.82%
0.82%
Reduce
26 139.94K $814.46K 0.79%
0.79%
Reduce
27 500.00K $795.00K 0.77%
0.77%
New
28 463.72K $795.00K 0.77%
0.77%
Add
29 212.78K $738.36K 0.72%
0.72%
New
30 630.18K $686.90K 0.67%
0.67%
Add
31 294.55K $665.68K 0.65%
0.65%
New
32 110.00K $656.70K 0.64%
0.64%
Hold
33 367.37K $615.12K 0.60%
0.60%
Reduce
34 20.61K $615.12K 0.60%
0.60%
New
35 200.65K $603.95K 0.59%
0.59%
Hold
36 131.16K $581.04K 0.56%
0.56%
New
37 102.27K $561.43K 0.55%
0.55%
Reduce
38 620.59K $500.81K 0.49%
0.49%
Add
39 100.00K $488.00K 0.47%
0.47%
Reduce
40 167.58K $413.92K 0.40%
0.40%
Add
41 483.65K $398.48K 0.39%
0.39%
New
42 68.08K $394.21K 0.38%
0.38%
New
43 238.95K $346.48K 0.34%
0.34%
Add
44 95.75K $343.73K 0.33%
0.33%
Reduce
45 278.19K $275.41K 0.27%
0.27%
New
46 21.55K $248.69K 0.24%
0.24%
New
47 508.27K $203.50K 0.20%
0.20%
Reduce
48 50.00K $203.50K 0.20%
0.20%
New
49 250.00K $200.03K 0.20%
0.20%
Reduce
50 50.00K $188.00K 0.18%
0.18%
New

FAQ

What did Stonepine Capital Management, LLC buy in 2025-Q1?

In its 2025-Q1 13F filing, Stonepine Capital Management, LLC reported 66 equity positions worth $102.76M in aggregate; its largest disclosed positions were ANIP ($13.65M), EOLS ($13.65M), OPTN ($7.23M).

How large is Stonepine Capital Management, LLC's portfolio?

Stonepine Capital Management, LLC reported $102.76M of long equity holdings across 66 positions as of 2025-Q1. Top-10 holdings account for 58.1% of reported value.

What is Stonepine Capital Management, LLC's investment style?

HoldingsHub classifies the portfolio as Small / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/stonepine-capital-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →